Background: Animal-derived, protein-containing surfactants perform better vs. non–protein-containing surfactants for prevention and treatment of Respiratory Distress Syndrome (RDS). A new generation, ...
LONDON, GREATER LONDON , UNITED KINGDOM, January 21, 2025 /EINPresswire / -- How Is The Curosurf Poractant Alfa Market Size Expected To Develop? The Curosurf ...
Napa, CA and Parma, Italy (May 7, 2007) -- Data presented today at the Pediatric Academic Societies’ Annual Meeting demonstrate that premature infants with neonatal Respiratory Distress Syndrome (RDS) ...
Amherst, New York-based ONY filed the suit last week in U.S. District Court in Buffalo, the Buffalo News first reported. Cornerstone, based in Cary, North Carolina, has not yet filed an answer to the ...
Cornerstone Therapeutics, a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products for the hospital and respiratory markets, announced a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results